Intrathecal Onasemnogene abeparvovec for Spinal Muscular Atrophy Treatment-Experienced Patients
- Researchers from leading medical institutions in the United States, Spain, France, and Japan are collaborating to improve understanding and treatment of a rare neurological disorder affecting children.This international...
- The collaboration focuses on advancing research into the genetic and clinical aspects of this rare condition, aiming to develop more effective diagnostic tools and therapeutic interventions. Specific details...
- This initiative highlights the growing importance of international partnerships in addressing complex medical challenges and improving outcomes for children with rare diseases.
International Collaboration advances Research on Rare Childhood Neurological Disorder
Researchers from leading medical institutions in the United States, Spain, France, and Japan are collaborating to improve understanding and treatment of a rare neurological disorder affecting children.This international effort brings together expertise from the American Family Children’s Hospital (University of Wisconsin), Hospital Universitari Vall d’Hebron (barcelona), Hôpital femme Mère Enfant (Lyon), Kurume University School of Medicine, Tokyo Women’s Medical University, and Toulouse University Hospital Center.
Key Researchers and Institutions
- Jennifer M. kwon, American Family Children’s Hospital, University of Wisconsin School of Medicine and Public health, Madison, WI, USA
- Francina munell, Department of Pediatric neurology, Hospital Universitari Vall d’Hebron, Barcelona, Spain
- Laure Le Goff, Department of Physical Medicine and Rehabilitation, Hôpital Femme Mère Enfant – Hospices Civils de Lyon, lyon, France
- Kotaro Yuge, Department of pediatrics and Child Health, Kurume University School of Medicine, Kurume, Japan
- Tamaki Kato, Institute of Medical Genetics, Tokyo Women’s Medical University, Tokyo, Japan
The collaboration focuses on advancing research into the genetic and clinical aspects of this rare condition, aiming to develop more effective diagnostic tools and therapeutic interventions. Specific details regarding the disorder and research findings are currently under development and will be published in peer-reviewed journals.
This initiative highlights the growing importance of international partnerships in addressing complex medical challenges and improving outcomes for children with rare diseases.
